1 Min Read
Jan 3 (Reuters) - Kite Pharma Inc :
* Kite pharma - submitted an investigational new drug (ind) application with U.S. Food and drug administration to initiate a phase 1 trial of kite-718 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.